Results
177
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
177 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EH | US$12.59 | 3.1% | -43.8% | US$743.6m | US$24.98 | PS36.4x | E74.3% | n/a | Capital Goods | ||
CRDO | US$26.87 | 1.2% | 84.8% | US$4.1b | US$32.17 | PS23x | E60.9% | n/a | Semiconductors | ||
ATAT | US$16.77 | 6.7% | -21.1% | US$2.2b | US$26.57 | PE17x | E21.6% | 0.9% | Consumer Services | ||
HIMS | US$15.85 | -14.4% | 120.4% | US$3.5b | US$21.77 | PE190.1x | E40.5% | n/a | Healthcare | ||
PDD | US$138.02 | 8.0% | 62.9% | US$184.9b | US$209.41 | PE17.2x | E21.7% | n/a | Retail | ||
TBBB | US$27.01 | -0.1% | n/a | US$2.9b | US$26.26 | PS1.2x | E70.7% | n/a | Consumer Retailing | ||
GCT | US$24.14 | -12.0% | 127.1% | US$955.9m | US$52.57 | PE8.8x | E25.4% | n/a | Retail | ||
VCTR | US$47.03 | -6.3% | 41.6% | US$2.9b | US$52.00 | PE13.9x | E34.0% | 3.1% | Diversified Financials | ||
CG | US$39.23 | -17.9% | 22.3% | US$13.6b | US$47.62 | PS5x | E22.8% | 3.6% | Diversified Financials | ||
SMCI | US$509.94 | -24.1% | 84.0% | US$28.9b | US$905.18 | PE24.7x | E31.2% | n/a | Tech | ||
CLNN | US$4.41 | -1.6% | -66.8% | US$29.0m | US$77.00 | PS64.2x | E63.9% | n/a | Pharmaceuticals & Biotech | ||
ZKH | US$2.77 | -2.1% | n/a | US$441.3m | US$15.74 | PB1x | E104.4% | n/a | Capital Goods | ||
MAX | US$15.81 | -4.7% | 82.4% | US$1.1b | US$24.67 | PS1.7x | E59.4% | n/a | Media | ||
CARG | US$22.40 | -7.1% | 24.0% | US$2.3b | US$27.00 | PE64.3x | E29.2% | n/a | Media | ||
HOFV | US$2.46 | -0.6% | -71.4% | US$15.6m | US$8.00 | PB0.1x | E71.1% | n/a | Consumer Services | ||
WULF | US$3.88 | -5.6% | 54.6% | US$1.1b | US$6.84 | PS12.9x | E99.5% | n/a | Software | ||
CBNK | US$23.79 | -4.8% | 15.2% | US$325.4m | US$28.00 | PB1.2x | E33.6% | 1.7% | Banks | ||
INMB | US$7.59 | -4.0% | -9.6% | US$139.5m | US$19.67 | PS1766.5x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$33.70 | -0.5% | 121.4% | US$3.2b | US$35.30 | PS11.2x | E98.5% | n/a | Software | ||
MP | US$10.97 | -13.5% | -52.1% | US$1.7b | US$21.54 | PS10.4x | E72.0% | n/a | Materials | ||
ONON | US$39.04 | -3.0% | 9.3% | US$11.8b | US$44.38 | PE85.1x | E25.8% | n/a | Consumer Durables | ||
RYAN | US$65.45 | 4.7% | 49.0% | US$17.0b | US$64.08 | PE100.4x | E51.1% | 0.7% | Insurance | ||
MDGL | US$243.64 | -12.5% | 41.9% | US$5.1b | US$363.79 | PS361.4x | E68.0% | n/a | Pharmaceuticals & Biotech | ||
HSAI | US$3.66 | -15.1% | -66.9% | US$458.9m | US$8.98 | PS1.9x | E71.0% | n/a | Automobiles |